Orion - Decisions of general meeting

Orion Corporation: Decisions by the AGM on 25 March 2014

ORION CORPORATION        STOCK EXCHANGE RELEASE        25 MARCH 2014 3.30 p.m.
EET



Orion Corporation: Decisions by the AGM on 25 March 2014


At the Annual General Meeting of Orion Corporation held today, the following
decisions were made:
  * A dividend of EUR 1.25 per share was confirmed to be paid for 2013. The
    record date for the dividend payment is 28 March 2014 and the payment date
    is 4 April 2014.
  * The proposals concerning the election and remuneration of the Board of
    Directors and the auditor, the number of the members of the Board of
    Directors and amendment of Section 12 of the Articles of Association were
    approved.
  * Sirpa Jalkanen, Eero Karvonen, Timo Maasilta, Hannu Syrjänen, Heikki
    Westerlund and Jukka Ylppö were re-elected to the Board of Directors. Mikael
    Silvennoinen was elected as a new member. Hannu Syrjänen was re-elected as
    Chairman.


The Annual General Meeting of Orion Corporation was held today in Helsinki. The
following matters were handled at the meeting:

Adoption of the Financial Statements for 1 January - 31 December 2013
The AGM confirmed the Financial Statements of the parent company and the Group
as per 31 December 2013.

Dividend EUR 1.25 per share
The proposed dividend of EUR 1.25 per share was approved. The record date for
the dividend payment is 28 March 2014 and the payment date is 4 April 2014.

Discharge from liability
The members of the Board of Directors and the President and CEO were discharged
from liability for the financial period of 1 January - 31 December 2013.

Remunerations to be paid to the Board of Directors
As  an annual fee for the term of office of the Board of Directors, the Chairman
shall  receive EUR  76,000, the Vice  Chairman shall  receive EUR 51,000 and the
other members shall receive EUR 38,000 each. As a fee for each meeting attended,
the  Chairman shall receive EUR 1,200, the  Vice Chairman shall receive EUR 900
and  the other members  shall receive EUR  600 each. The travel  expenses of all
Board  members shall be paid in accordance with previously adopted practice. The
afore-mentioned  fees for each committee meeting  attended shall also be paid to
the Chairmen and to the members of the committees established by the Board.

Of the annual fee, 60% shall be paid in cash and 40% in Orion Corporation B-
shares, which shall be acquired to the members during 31 March - 4 April 2014
from the stock exchange in amounts corresponding to EUR 30,400 for the Chairman,
EUR 20,400 for the Vice Chairman and EUR 15,200 for each of the other members.
The part of the annual fee that is to be paid in cash corresponds to the
approximate sum necessary for the payment of the income taxes on the fees and
shall be paid no later than 30 April 2014. The annual fees encompass the full
term of office of the Board of Directors.

Composition of the Board of Directors
Hannu Syrjänen re-elected as Chairman
The number of members in the Board of Directors was confirmed to be seven. Sirpa
Jalkanen, Eero Karvonen, Timo Maasilta, Hannu Syrjänen, Heikki Westerlund and
Jukka Ylppö were re-elected and Mikael Silvennoinen was elected as a new member
to the Board of Directors for the next term of office. Hannu Syrjänen was re-
elected as Chairman.


Auditor and their remuneration
PricewaterhouseCoopers Oy, authorised public accountants, were re-elected as the
Company's auditor. The remunerations to the Auditor shall be paid on the basis
of invoicing approved by the Company.

Amendment to Section 12 of the Articles of Association
Section 12 of the Articles of Association of the Company was decided to be
amended so that the notice to convene a General Meeting of the Shareholders
shall be published on the Company's website no earlier than two (2) months and
no later than three (3) weeks before the General Meeting, however, no later than
nine (9) days before the record date of the General Meeting


The minutes of the AGM will be provided in Finnish only, and they will become
available on Orion's internet website, address www.orion.fi/agm2014, no later
than 8 April 2014.


Orion Corporation



Timo Lappalainen                Olli Huotari
President and CEO              Senior Vice President, Corporate Functions


Contact person:
Olli Huotari, Senior Vice President, Corporate Functions, phone
+358 50 966 3054

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. Pharmaceutical R&D focuses on central nervous system drugs,
oncology and critical care drugs, and Easyhaler® pulmonary drugs.

Orion's net sales in 2013 amounted to EUR 1,007 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ OMX Helsinki.


[HUG#1771282]